EF
ABBV icon

Evanson Financial’s AbbVie ABBV Stock Holding History

Evanson Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
+3,995
New +$860K 0.05% 140

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Evanson Financial's ABBV Position: Q2 2026 in Review

Evanson Financial opened a new position in AbbVie (ABBV) in Q2 2026: 3,995 shares worth $1.01M. The stake represents 0.05% of the portfolio and ranks #140 among its holdings.

4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Evanson Financial held 3,995 shares of AbbVie worth $1.01M as of Q2 2026.
  • AbbVie was a new Evanson Financial position in Q2 2026.
  • AbbVie made up 0.05% of Evanson Financial's portfolio in Q2 2026, its #140 holding.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Evanson Financial's 13F filing for Q2 2026, filed 7 Jul 2026.